JOIN THE MOVEMENT: BECOME A MEMBER!
Stand up for women's health and normalize conversations about sex, sexuality, menstruation and reproductive health challenges.
Click here to learn more.

Federal Government on Products

  1. A listing of drugs pursuant to sub-section C.08.004.1(9) of the Food and Drug Regulations.
  2. An NOC/c is authorization to market a drug (i.e. a Notice of Compliance (NOC)), with the condition that the Sponsor undertake additional studies to verify the clinical benefit. The NOC, qualifying under the NOC/c policy, is issued under section C.08.004 of the Food and Drug Regulations.
  3. The data extract is a series of compressed ASCII text files of the Notice of Compliance (NOC) database.
  4. Health Canada Summary Basis of Decision October 23, 2019. Ogivri, trastuzumab, 440 mg/vial and 150 mg/vial, lyophilized powder, BGP Pharma ULC, Submission Control Number 204579
  5. Health Canada Summary Basis of Decision 2019-10-02. Onpattro, patisiran (as patisiran sodium), 2 mg/mL, solution, Alnylam Pharmaceuticals. Submission Control Number 221896

Communication

The WHC Mandate

WHC_Mandate.pdf
Popular 256.17 KB
Monday, 04 November 2019

Letter to Minister Shandro

Minister-Shandro_letter.pdf
Popular 131.86 KB
Monday, 04 November 2019